@swog.org #S2200 is also still accruing!! An important trial since there are so few for #papillaryRCC. Also happy to chat w/ patients considering this for metastatic #papillarykidneycancer. In this limited non-clear cell space, patients deserve more trials like this! #SWOGFall2025

🎥 New on #OncologyBytes from #IUCS2024
Dr Michele Maffezzoli validates the GRANT Score in papillary RCC - 1,900+ patients, real-world data.
📊 Accurate, simple, risk-stratified survival prediction.
📺 Watch: youtu.be/38shXSOsUNI
🌐 Learn more at: oncoassist.com
#PapillaryRCC #GRANTScore #Oncoassist